The possible treatment of migraine with carteolol hydrochloride.
Shapiro
M K
MK
Gorn
R
R
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002354:Carteolol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D002354:Carteolol